PCR-CIT China Chengdu Valves 2017
The foundational Course for Valve Interventions in Greater China
Under the joint-organization of PCR, CIT (China Interventional Therapeutics), and West China Hospital of Sichuan University, the third edition of PCR-CIT China Chengdu Valves (PCCV) will be held from 24 to 26 November 2017 in Chengdu, China.
PCR-CIT China Chengdu Valves is organized based on the successful experience of PCR London Valves, under the theme of Transcatheter Aortic Valve Implantation (TAVI). This educational meeting focuses on basic skill training through hands-on practice, live demonstrations, academic lectures and case-based discussions.
Transcatheter valve therapy has evolved as an established field in clinical practice, with proved effectiveness of improving survival and quality of life in patients deemed inoperable or at high risk for surgical valve replacement. Over the past twenty years, PCR Organization has been helping the cardiovascular community to share knowledge, experience and practice; they have successfully guided and promoted transcatheter valve therapy stretching from Europe to the West. However, the development of transcatheter valve therapy is still at its preliminary stage in mainland China and the Asia-Pacific region.
The PCCV course helps improve the ability of doctors in China and the Asia-Pacific region to use this technology and hopefully promote its development for the benefits of the patients.
Goals and Objectives
The primary objectives of the PCCV Course are:
- providing practical training on transcatheter heart valve therapy, especially transcatheter aortic valve implantation (TAVI), in mainland China and the Asia-Pacific region
- teaching physicians to use this technology, or strenghten their knowledge for the benefit of patients in the region
- establishing an interactive academic exchange platform between Asian and Western physicians
In the next few years, the Course aims at being recognized internationally as the highest academic and educational conferences on TAVI in the Asia-Pacific region.
Who should attend?
The PCCV course is designed for cardiologists who are planning to initiate TAVI projects in their institutions or who have been dedicated to this field.
Nevertheless, any doctor who is interested in TAVI and wants to learn the procedure or get updated with the latest advances is welcome to attend this educational meeting.
Get a Glimpse of PCR China Chengdu Valves 2016 and get ready for this year's edition!